Impact of Autologous Stem Cell Transplant (ASCT) Versus Consolidation on Health-Related Quality of Life (HRQoL) for Patients with Multiple Myeloma Receiving Carfilzomib Maintenance... by Popat, Rakesh, Wilson, William, Camilleri, Marquita, Ramasamy, Karthik, Streetly, Matthew, Sive, Jonathan, Bygrave, Ceri, Benjamin, Reuben, Chapman, Michael A, Chavda, Selina J, Phillips, Beth, Cuadrado, Maria del Mar, Pang, Gavin, Jenner, Richard, Dadaga, Tushhar, Kamora, Sumaiya, de Tute, Ruth M., Cavenagh, James, Clifton-Hadley, Laura, Owen, Roger G, Yong, Kwee

Get full text

Developing a Flow Cytometric Signature of Carfilzomib Responsiveness in Myeloma by Walker, Ieuan, D'arcy, Venetia, Rodriguez Romera, Antonio, Anderson, Georgina, Aubareda, Anna, Roy, James, Khandelwal, Garima, Wilson, William, Fitzsimons, Evelyn, Galas-Filipowicz, Daria, Foster, Kane, Popat, Rakesh, Ramasamy, Karthik, Streetly, Matthew, Bygrave, Ceri, Benjamin, Reuben, de Tute, Ruth M., Camilleri, Marquita, Chavda, Selina J, Pang, Gavin, Dadaga, Tushhar, Kamora, Sumaiya, Cavenagh, James, Phillips, Elizabeth H., Clifton-Hadley, Laura, Owen, Roger G, Herrero, Javier, Yong, Kwee, Chapman, Michael A

Get full text

PET-CT for Assessment of Multiple Myeloma Disease Burden and Metabolic Response before and after Carfilzomib-Based Induction, Consolidation and Carfilzomib Maintenance Therapy: Dat... by Bygrave, Ceri A, Subesinghe, Manil, Wilson, William, Popat, Rakesh, Ramasamy, Karthik, Pang, Gavin, Jenner, Richard, Kamora, Sumaiya, Dadaga, Tushhar, Pike, Lucy, Streetly, Matthew, Camilleri, Marquita, Owen, Roger G, Cavenagh, James, Sive, Jonathan, Chapman, Michael, Phillips, Elizabeth H, Chavda, Selina J, Cuadrado, Maria del Mar, Benjamin, Reuben, Eccersley, Lydia, Moore, Sally, Banerjee, Lalita, Clifton-Hadley, Laura, Barrington, Sally F, Yong, Kwee

Get full text

Upfront Autologous Stem Cell Transplantation (ASCT) Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Consolidation in Transplant-Eligible, Newly Diagnosed (NDTE) Multiple Myelom... by Yong, Kwee, Wilson, William, Camilleri, Marquita, Ramasamy, Karthik, Streetly, Matthew, Sive, Jonathan, Bygrave, Ceri A, Chapman, Michael, de Tute, Ruth M., Chavda, Selina J, Phillips, Elizabeth H, Cuadrado, Maria del Mar, Pang, Gavin, Jenner, Richard, Dadaga, Tushhar, Kamora, Sumaiya, Cavenagh, James, Clifton-Hadley, Laura, Owen, Roger G, Popat, Rakesh

Get full text

COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial by Camilleri, Marquita, Sive, Jonathan, Wilson, William, Pang, Gavin, Jenner, Richard, Phillips, Elizabeth, Popat, Rakesh, Ramasamy, Karthik, Bygrave, Ceri, Dadaga, Tushhar, Streetly, Matthew, Cavenagh, James, Chapman, Mike, Barrington, Sally, Pike, Lucy, Owen, Roger, Clifton‐Hadley, Laura, Yong, Kwee

Request full text

P-084: Bone marrow of patients post ASCT, but not chemotherapy consolidation, contains expanded T cell receptor clonotypes that are present at diagnosis: results from the Phase 2 C... by Foster, Kane, Galas-Filipowicz, Daria, Fitzsimons, Evie, Wilson, William, Lee, Lydia, Byrne, Suzanne, Ramasamy, Karthik, Popat, Rakesh, Chapman, Michael, Streetly, Matthew, Bygrave, Ceri, Benjamin, Reuben, de Tute, Ruth, Camilleri, Marquita, Chavda, Selina, Philips, Elizabeth, Pang, Gavin, Jenner, Richard, Dadaga, Tushhar, Kamora, Sumaiya, Cavenagh, James, Clifton-Hadley, Laura, Owen, Roger, Chain, Benny, Yong, Kwee

Get full text

OAB-018: From CARDAMON to CoMMpass: a mutational signature that predicts carfilzomib-specific outcomes in myeloma by Walker, Ieuan, Khandelwal, Garima, D’Arcy, Venetia, Wilson, William, Fitzsimons, Evie, Galas-Filipowicz, Daria, Popat, Rakesh, Ramasamy, Karthik, Streetly, Matthew, Bygrave, Ceri, Benjamin, Reuben, de Tute, Ruth, Camilleri, Marquita, Chavda, Selina, Pang, Gavin, Jenner, Richard, Dadaga, Tushhar, Kamora, Sumaiya, Cavenagh, James, Clifton-Hadley, Laura, Owen, Roger, Herrero, Javier, Yong, Kwee, Chapman, Michael

Get full text

P-228: ASCT does not benefit patients who are MRD negative following induction therapy: updated results from the Phase 2 Cardamon study by Yong, Kwee, Wilson, William, de Tute, Ruth, Camilleri, Marquita, Ramasamy, Karthik, Streetly, Matthew, Sive, Jonathan, Bygrave, Ceri, Benjamin, Reuben, Chapman, Michael, Chavda, Selina, Philips, Elizabeth, del Mar Cuadrado, Maria, Pang, Gavin, Jenner, Richard, Dadaga, Tushhar, Kamora, Sumaiya, Cavenagh, James, Clifton-Hadley, Laura, Owen, Roger, Popat, Rakesh

Get full text

OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed... by Popat, Rakesh, Wilson, William, Camilleri, Marquita, Tute, Ruth De, Pang, Gavin, Jenner, Richard, Dadaga, Tushhar, Kamora, Sumaiya, Streetly, Matthew, Ramasamy, Karthik, Phillips, Elizabeth, Chapman, Mike, Bygrave, Ceri, Cavenagh, James, Sive, Jonathan, Benjamin, Reuben, Eccersley, Lydia, Hassan, Sandra, Willis, Fenella, Clifton-Hadley, Laura, Owen, Roger, Yong, Kwee

Get full text